Final Guidance From FDA Maintains Relaxed Restrictions On Face Coverings
The US Food and Drug Administration continues to ease up on rules around various types of face protectors and respirators throughout the duration of the COVID-19 pandemic, so long as they do not pose an undue risk to the public health and provide proper labeling.
You may also be interested in...
As the US heads into a COVID-19 storm with grave concerns about the lack of face masks and respirators for health care workers, the FDA has further relaxed federal oversight for such products, giving more responsibility to employers
The Affordable Care Act requires health insurers to cover contraceptives; some lawmakers in the US House want to make sure those requirements are upheld.
The US FDA issued a safety communication to patients and health care providers about the potential for overdose when using ENFit low dose tip syringes, and also told manufacturers to update labeling to account for the risk.